Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 août 2025 13h00 HE | Source: DelveInsight Business Research LLP

AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

New York, USA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the...
01 nov. 2023 04h00 HE | Source: NorthX Biologics Matfors AB

NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support

NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support
27 avr. 2023 13h00 HE | Source: DelveInsight Business Research LLP

AAV Vectors in Gene Therapy Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 70+ Companies Working in the Domain

New York, USA, April 27, 2023 (GLOBE NEWSWIRE) -- AAV Vectors in Gene Therapy Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 70+ Companies Working in the Domain ...